CureVac Manufacturing GmbH, a wholly owned subsidiary of CureVac SE, is a biopharmaceutical company producing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on innovative cancer immunotherapies, prophylactic vaccines and molecular therapies. Currently, all RNA people are striving to achieve our main goal: To bring multiple best-in-class mRNA drugs to market.
CureVac Manufacturing GmbH
Human Resources
Alba Ardito
Friedrich-Miescher-Straße 15
72076 Tübingen
Www.curevac.com